Pharmala Biotech Hldgs Stock (OTC: MDXXF)

Pharmala Biotech Hldgs (OTC:MDXXF) Stock, Quote.Headers.trade-ideas

Pharmala Biotech Holdings Inc is focused on manufacturing and sales of MDMA and MDXX Active Pharmaceutical Ingredients (API) for use in clinical research. Its drug API is manufactured and encapsulated under GMP conditions. The company generates revenue from the sale of tablets and raw MDMA and MDXX compounds/formulations and royalties from licensing of its IP.

Cannabis

Psychedelics

MDXXF

PharmAla Biotech will supply GMP LaNeo MDMA to Mt. Sinai Health System for clinical research, advancing therapy for neurological disorders.

PharmAla Biotech To Supply LaNeo MDMA For Mt. Sinai Clinical Trial

News

PharmAla Biotech will supply the University of Texas, San Antonio with a novel LaNeo MDMA dosage form for a clinical trial, advancing MDMA research and innovation.

PharmAla Biotech To Supply University Of Texas, San Antonio For Clinical Trial

Press Releases

PharmAla Biotech to supply MDMA for a clinical trial at Harvard&#39;s Maclean Hospital. Company also explores European distribution at CPHI Milan Conference.

PharmAla Biotech To Supply MDMA For Harvard&#39;s Maclean Hospital Clinical Trial

PHARMALA BIOTECH HLDG INC by PharmAla Biotech Holdings Inc.

Comments

Pharmala Biotech Hldgs

Pharmala Biotech Hldgs (OTC:MDXXF) Stock, Quote.Headers.trade-ideas

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga